Research output per year
Research output per year
Personal profile
Research interests
I am a postdoctoral researcher and epidemiologist with a special interest in the use of patient-reported outcome measures and shared decision-making in chronic care.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Thomas Wieringa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Development of an e-learning environment with a user-centered design process: an example in the education of epidemiology and medical statistics
Wieringa, T. H., van de Belt, H. A., Burgerhof, J. G. M., Groen, H., Postmus, D., Smidt, N., Nolte, I. M., Thio, C. H. L., la Bastide-van Gemert, S., Schroevers, M. J., Ranchor, A. V., Wardenaar, K. J., Hietkamp-Hoekstra, S. D., Nijmeijer, R., Tamasi, K., de Bock, G. H., Snieder, H. & El-Baz, N., 21-Mar-2025, ZENODO, 14 p.Research output: Working paper › Preprint › Academic
Open AccessFile2 Downloads (Pure) -
The role of time in involving patients with cancer in treatment decision making: A scoping review
Wieringa, T. H., León-García, M., Espinoza Suárez, N. R., Hernández-Leal, M. J., Jacome, C. S., Zisman-Ilani, Y., Otten, R. H. J., Montori, V. M. & Pieterse, A. H., Aug-2024, In: Patient Education and Counseling. 125, 15 p., 108285.Research output: Contribution to journal › Review article › peer-review
Open AccessFile7 Citations (Scopus)12 Downloads (Pure) -
Adverse Childhood Experiences and frailty in later life: a prospective population-based cohort study
Dimitriadis, M. M., Jeuring, H. W., Marijnissen, R. M., Wieringa, T. H., Hoogendijk, E. O. & Oude Voshaar, R. C., 1-Feb-2023, In: Age and Ageing. 52, 2, 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile7 Citations (Scopus)118 Downloads (Pure) -
Challenges to acquire similar learning outcomes across four parallel thematic learning communities in a medical undergraduate curriculum
Zhou, Y., Wieringa, T. H., Brouwer, J., Diemers, A. D. & Bos, N. A., 18-May-2023, In: BMC Medical Education. 23, 1, 14 p., 349.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile55 Downloads (Pure) -
Clinical longevity of intracoronal restorations made of gold, lithium disilicate, leucite, and indirect resin composite: a systematic review and meta-analysis
Bresser, R. A., Hofsteenge, J. W., Wieringa, T. H., Braun, P. G., Cune, M. S., Özcan, M. & Gresnigt, M. M. M., Sept-2023, In: Clinical Oral Investigations. 27, 9, p. 4877-4896 20 p.Research output: Contribution to journal › Review article › peer-review
Open AccessFile10 Citations (Scopus)64 Downloads (Pure)
-
Frontiers in Clinical Diabetes and Healthcare (Journal)
Wieringa, T. (Editorial board member)
May-2020 → May-2023Activity: Peer-review and editorial work › Editorial work › Academic
-
Advisory board member
Wieringa, T. (Consultant)
May-2019Activity: External assignment (consultancy, appointment, outreach) › Consultancy › Academic
-
Improved diabetes medication convenience in persons with type 2 diabetes after switching to insulin glargine 300 U/mL: Results of the observational OPTIN-D study
Wieringa, T. (Speaker)
20-Jan-2018Activity: Talk and presentation › Academic presentation › Academic
-
Improved diabetes medication convenience in persons with type 2 diabetes after switching to insulin glargine 300 U/mL (U-300) - The observational OPTIN-D study
Wieringa, T. (Speaker)
22-Jun-2018 → 26-Jun-2018Activity: Talk and presentation › Academic presentation › Academic
-
An observational study documenting Patient Reported Outcomes (PROs) of people with type 2 diabetes treated with insulin glargine-300 U/mL
Wieringa, T. (Speaker)
29-Sept-2017Activity: Talk and presentation › Academic presentation › Academic